Trevi Therapeutics Inc (TRVI) — Financial Flexibility Index
Trevi Therapeutics Inc (TRVI) has a Financial Flexibility Index of -1.92x as of June 2026. Free cash flow of $-17.30 Million (operating CF $-17.43 Million minus capex $124.00K) represents -2% of total liabilities ($9.01 Million). Check TRVI tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Trevi Therapeutics Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Trevi Therapeutics Inc across 10 annual periods. For the full cash flow conversion analysis, see TRVI cash flow metrics.
Annual Financial Flexibility Index for Trevi Therapeutics Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Trevi Therapeutics Inc. Explore how well can Trevi Therapeutics Inc service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.13x | $-42.08 Million | $-42.09 Million | $10.20 Million | ▼ -21.5% |
| 2024 | -3.40x | $-38.22 Million | $-38.26 Million | $11.26 Million | ▲ +26.3% |
| 2023 | -4.61x | $-31.57 Million | $-31.71 Million | $6.86 Million | ▼ -155.7% |
| 2022 | -1.80x | $-28.02 Million | $-28.18 Million | $15.56 Million | ▼ -33.9% |
| 2021 | -1.35x | $-28.79 Million | $-28.95 Million | $21.40 Million | ▲ +7.8% |
| 2020 | -1.46x | $-28.97 Million | $-29.00 Million | $19.85 Million | ▲ +65.5% |
| 2019 | -4.23x | $-23.08 Million | $-23.09 Million | $5.46 Million | ▲ +25.8% |
| 2018 | -5.70x | $-18.13 Million | $-18.29 Million | $3.18 Million | ▼ -433.2% |
| 2017 | -1.07x | $-7.96 Million | $-7.97 Million | $7.45 Million | ▼ -146.8% |
| 2016 | -0.43x | $-11.18 Million | $-11.19 Million | $25.82 Million | — |